undamentalytics Newsletter

Neuroone Medical Technologies vs Work Medical Technology Group

Neuroone Medical Technologies and Work Medical Technology Group are similar in size: $9.1m and $9.8m of revenue in their latest fiscal years. Neuroone Medical Technologies grew faster (163.5% against -14.4%). Work Medical Technology Group kept more of each dollar of sales as profit: a net margin of -10.9% against -39.6%.

Latest fiscal yearNeuroone Medical TechnologiesNMTC, 2025Work Medical Technology GroupWOK, 2025
Revenue $9.1m $9.8m
Revenue growth 163.5% -14.4%
Net income −$3.6m −$1.1m
Operating margin — —
Net margin -39.6% -10.9%
Return on equity -91.3% -6.8%
Free cash flow −$2.9m $4.9m
Cash $6.6m $4.1m
Total debt $0 $6.4m
Debt to equity — 34.9%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 18 —
Market value $8.2m $30.9m
Price vs our value range — —
Moat score 21 (Weak) —
Insider trades, 12 months 2 buys, 6 sales 10 buys, 5 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.